(Q39001266)

8 September 2017

title

Aspirin inhibits proliferation and induces apoptosis of multiple myeloma cells through regulation of Bcl-2 and Bax and suppression of VEGF. (English)

1 reference

8 September 2017

1 reference

1 reference

Jiang-Hua Ding

1

1 reference

8 September 2017

Li-Ya Yuan

series ordinal

2

1 reference

8 September 2017

Rui-Bin Huang

series ordinal

3

1 reference

8 September 2017

Guo-An Chen

series ordinal

4

1 reference

8 September 2017

language of work or name

1 reference

13 May 2014

1 reference

European Journal of Haematology

8 September 2017

published in

1 reference

8 September 2017

volume

93

1 reference

8 September 2017

issue

4

1 reference

8 September 2017

page(s)

329-339

1 reference

8 September 2017

cites work

Cancer statistics, 2013

1 reference

Dosing frequency of aspirin and prevention of heart attacks and strokes

21 January 2018

1 reference

Aspirin for primary prevention of myocardial infarction: what is the evidence?

21 January 2018

1 reference

The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma

21 January 2018

1 reference

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

21 January 2018

1 reference

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

21 January 2018

1 reference

Aspirin and non-aspirin non-steroidal anti-inflammatory drug use and risk of lung cancer.

21 January 2018

1 reference

Commentary: the association between low-dose aspirin use and the incidence of colorectal cancer.

21 January 2018

1 reference

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence

21 January 2018

1 reference

Aspirin induces apoptosis in YD-8 human oral squamous carcinoma cells through activation of caspases, down-regulation of Mcl-1, and inactivation of ERK-1/2 and AKT.

21 January 2018

1 reference

Aspirin inhibits ErbB2 to induce apoptosis in cervical cancer cells

21 January 2018

1 reference

Aspirin activates the NF-kappaB signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer

21 January 2018

1 reference

Aspirin prevents apoptosis and NF-kappaB activation induced by H2O2 in hela cells

21 January 2018

1 reference

Apoptosis induced by aspirin and 5-fluorouracil in human colonic adenocarcinoma cells

21 January 2018

1 reference

Additive inhibition of colorectal cancer cell lines by aspirin and bortezomib.

21 January 2018

1 reference

Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases

21 January 2018

1 reference

MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs.

21 January 2018

1 reference

Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma

21 January 2018

1 reference

Aspirin use in myeloma: a note of caution regarding potential tumour necrosis factor-alpha elevation

21 January 2018

1 reference

Does low-dose aspirin have antineoplastic effects in multiple myeloma?

21 January 2018

1 reference

Regular aspirin use and risk of multiple myeloma: a prospective analysis in the health professionals follow-up study and nurses' health study.

21 January 2018

1 reference

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

21 January 2018

1 reference

Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism

21 January 2018

1 reference

Aspirin enhances TRAIL-induced apoptosis via regulation of ERK1/2 activation in human cervical cancer cells.

21 January 2018

1 reference

Aspirin induces apoptosis in human leukemia cells independently of NF-kappaB and MAPKs through alteration of the Mcl-1/Noxa balance

21 January 2018

1 reference

Aspirin induces apoptosis through release of cytochrome c from mitochondria

21 January 2018

1 reference

Bax-induced apoptotic cell death

21 January 2018

1 reference

Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator

21 January 2018

1 reference

ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells.

21 January 2018

1 reference

Bortezomib mitigates adverse prognosis conferred by Bcl-2 overexpression in patients with relapsed/refractory multiple myeloma

21 January 2018

1 reference

Antisense p53 transduction leads to overexpression of bcl-2 and dexamethasone resistance in multiple myeloma

21 January 2018

1 reference

IL-6-independent expression of Mcl-1 in human multiple myeloma

21 January 2018

1 reference

Optimal drug therapy after aspirin-induced upper gastrointestinal bleeding

21 January 2018

1 reference

Inhibition of VEGF signaling pathways in multiple myeloma and other malignancies

21 January 2018

1 reference

VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis

21 January 2018

1 reference

The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma

21 January 2018

1 reference

The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions

21 January 2018

1 reference

Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma

21 January 2018

1 reference

Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide

21 January 2018

1 reference

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EJH.12352

1 reference

8 September 2017

1 reference